Announcement.
WEBINAR: No more missed pathogens. One metagenomic method for all.
REGISTER NOW
Enzymes that Unlock
Your Next Discovery
0
Resources
Company
Contact
X

Essential insights based on 3rd party publications:

Get the White Paper now
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X

Quantification Challenges of Chromatin — Associated Host Cell DNA:
An Underestimated Risk

  • Discover why host cell DNA quantities are often significantly underestimated.
  • Understand the limitation of conventional nucleases when degrading chromatin

Download the poster here
and get access to the
interactive Q&A

Get the Poster now
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Investors News

Nomination of Dr. Frank Mathias as Chairman of the Board

Jun 25, 2024

Tromsø, Norway, June 25th, 2024—ArcticZymes Technologies (OSE: AZT) Announces Nomination of Dr. Frank Mathias as Chairman of the Board

Read More
Read More

Notice of Annual General Meeting 2024

Jun 5, 2024

The annual general meeting (“AGM”) in ArcticZymes Technologies ASA will be held on Wednesday, June 26th, 2024, at 15.00 CET.

Read More
Read More

ArcticZymes Technologies Changes to the Board of Directors

May 13, 2024

Tromsø, Norway, May 13th, 2024—ArcticZymes Technologies (OSE: AZT) announces Nominations for new Board members and the resignations of the Chairman and a Board member.

Read More
Read More

Presentation of Q1 2024 Results

May 8, 2024

Tromsø, Norway, May 8th, 2024 – ArcticZymes Technologies (OSE: AZT) reported sales of NOK 30.0 million and an EBITDA of NOK 2.3 million for the first quarter of 2024.

Read More
Read More